DBC News 23.68 09/22/2014 04:39:54 DB Commodity Index Tracking

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DB Commodity Index Tracking Powershares (DBC) 23.68 $DBC

Here's How a Stronger Dollar Should Be Changing Your Investment Strategy
at The Street - Fri Sep 12, 9:08AM CDT
There may be a couple of ways to profit from the strengthening greenback, one of which is to simply buy it.

Oil Services Sector Stalls as Prices Plunge, Explorers Regroup
at The Street - Wed Sep 10, 1:00PM CDT
Further sell-offs could hit the oil services sector as fear premium fades and energy prices continue to fall.

Weak Start to September for Natural Gas ETFs: Will This Continue? - ETF News And Commentary
Sweta Killa - ZACKS - Mon Sep 08, 12:00PM CDT
The current bearish near-term sentiments for natural gas may keep investors on the sidelines.

Global X Plans Emerging Market Bond, Commodity ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 7:00AM CDT
Global X is putting more funds into the pipeline, looking to add products in the emerging market bond and commodity ETF segments.

First Week of DBC October 18th Options Trading
DividendChannel.com - Tue Feb 25, 10:50AM CST
Investors in DB Commodity Index Tracking Fund saw new options become available this week, for the October 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days...

[video] Quick Take: Don't Trust the Traditional 60/40 Portfolio Split
at The Street - Thu Feb 20, 11:10AM CST
The market is overvalued by 20% after last year's rally and bond yields remain at record lows, so the traditional 60/40 stock/bond split is not optimal, says Stephen Blumenthal, portfolio manager for the CMG Global Equity Fund.

3 Commodity ETFs Still Looking Strong - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 7:00AM CST
These ETFs have held up well and could be better commodity market plays this year.

PowerShares DB Commodity Index Tracking Fund Falls 1.04% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Sep 17, 5:31PM CDT
PowerShares DB Commodity Index Tracking Fund (AMEXBC) traded in a range yesterday that spanned from a low of $25.71 to a high of $26.03. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $26.01 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.04%, PowerShares DB Commodity Index Tracking Fund Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 17, 5:30PM CDT
PowerShares DB Commodity Index Tracking Fund (AMEXBC) traded in a range yesterday that spanned from a low of $25.71 to a high of $26.03. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $26.01 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Slump in Coffee ETF Continues - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Aug 27, 1:30PM CDT
Supply glut, tepid demand and a weakening Brazilian real have weakened coffee fundamentals.

Inside the New iShares Commodity ETF - ETF News And Commentary
Eric Dutram - ZACKS - Tue Aug 13, 7:11AM CDT
This new iShares ETF may help give investors exposure to commodities while reducing the impact of contango.

Are Inflationary Expectations Overblown?
Chad Karnes - ETFG - Tue Jul 16, 9:39PM CDT
It seems the law of large numbers does not always work out as it's supposed to. Taking a large group of consumer estimates for inflation has been underestimated for decades. Getting a large, diverse, number of inputs does not necessarily get you...

More Commodity ETFs: Credit Suisse Releases New ETNs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu Jun 13, 11:02AM CDT
Investors now have new commodity ETNs from Credit Suisse, giving broad exposure to the space.

Inside the Palladium ETF's Recent Surge (PALL) - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jun 12, 11:31AM CDT
Time to consider the palladium ETF as a momentum play?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rate and Betterment's Mortgage Play: Savings or Spin?

Updated Category News Views 151

So here’s the scoop: Rate just teamed up with Betterment on February 17, 2026, offering some pretty slick mortgage incentives for those sitting on at least $100K in their investment accounts. But let’s dig into the nitty-gritty before you start dreaming of that low-rate home loan. Betterment's Strategy: Solid Gains or Hype? The partnership aims to deliver discounted...

Continue Reading
UK Water Companies Gain Confidence After Regulatory Update

Updated Category News Views 253

Morgan Stanley Highlights UK Water Sector Improvements Investment risks surrounding listed UK water companies have significantly decreased following a key regulatory decision concerning water bill increases in England and Wales. According to analysts from Morgan Stanley, this development has created a more favorable landscape for investors in the sector. Key Insights From...

Continue Reading
SiLC Technologies Unveils Advanced Eyeonic Trace Scanner

Updated Category News Views 228

SiLC Technologies Introduces Eyeonic Trace Laser Line Scanner SiLC Technologies, a leader in the development of advanced integrated FMCW LiDAR solutions, recently announced an exciting new product: the Eyeonic Trace Laser Line Scanner. This state-of-the-art Class 1 Laser Line Scanner is engineered to achieve precise measurements of objects from distances of up to 10...

Continue Reading
Accord BioPharma Launches HERCESSI™ for Cancer Treatment

Updated Category News Views 94

Accord BioPharma Announces FDA Approval for HERCESSI™ Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has achieved a major milestone in cancer treatment with the FDA's approval of a new 420mg strength of HERCESSI™ (trastuzumab-strf). This biosimilar to Herceptin (trastuzumab) targets different types of HER2-overexpressing cancers, such as...

Continue Reading
Why Oklo Stock is Soaring This Week and What to Expect

Updated Category News Views 493

What’s Driving Oklo Inc’s Stock Surge? Oklo Inc (NYSE: OKLO) is making waves in the stock market as its shares witness impressive growth. Over the past month, the company has experienced a remarkable rally of approximately 60%. Investors are keen to learn about the driving forces behind this upward trend. Recent Positive Developments This recent surge can primarily be...

Continue Reading